STTK
Shattuck Labs Inc
NASDAQ: STTK · HEALTHCARE · BIOTECHNOLOGY
$7.15
+0.85% today
Updated 2026-04-30
Market cap
$583.49M
P/E ratio
—
P/S ratio
583.49x
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$1 – $8
Volume
0.6M
Shattuck Labs Inc (STTK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.90M | $-20.98M | $-33.66M | $-57.12M | $-94.50M | $-81.23M | $-60.52M | $-39.88M |
| Capital expenditures | $1.18M | $470000.00 | $727000.00 | $7.93M | $11.61M | $407000.00 | $59000.00 | $71000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $425000.00 | $461000.00 | $1.27M | $5.47M | $6.46M | $6.94M | $9.55M | $7.00M |
| Free cash flow | $-8.08M | $-21.45M | $-34.39M | $-65.04M | $-106.11M | $-81.64M | $-60.57M | $-39.95M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $150.88M | $-65.63M | $-44.89M | — | — | — |